Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000226755 | SCV000965641 | benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2019-07-26 | reviewed by expert panel | curation | The NM_001754.4:c.167T>C (p.Leu56Ser) variant has a MAF of 0.03259 (3.259%, 518/15,894 alleles) in the South Asian subpopulation of the ExAC cohort that is >/= 0.0015 (0.15%) (BA1). This variant is detected in homozygous state (56) in gnomAD population database (BP2). Transactivation assays demonstrating normal transactivation (80-115% of wt) and data from secondary assays demonstrate normal DNA binding, CBF-beta binding and sub-cellular localization (BS3; PMID: 23817177). Two patients reported in PMID:29365323 with AML. But PS4 can not apply in combined with BA1. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the ClinGen Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BA1, BS3, BP2. |
Invitae | RCV000226755 | SCV000287182 | benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003891806 | SCV000308031 | benign | RUNX1-related disorder | 2019-10-22 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Illumina Laboratory Services, |
RCV000226755 | SCV000435952 | benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Genome Diagnostics Laboratory, |
RCV000226755 | SCV000743126 | benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2015-01-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000680395 | SCV001753940 | benign | not provided | 2019-07-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31385734, 31289210, 11921279, 21343560, 27106701, 22753902, 28386644) |
Sema4, |
RCV002256141 | SCV002535853 | benign | Hereditary cancer-predisposing syndrome | 2020-10-21 | criteria provided, single submitter | curation | |
Ce |
RCV000680395 | SCV003916330 | benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | RUNX1: PP3, BS1, BS2 |
KCCC/NGS Laboratory, |
RCV002277588 | SCV004015357 | benign | Acute myeloid leukemia | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000226755 | SCV000745582 | benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2015-05-08 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000680395 | SCV001798345 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
ISTH- |
RCV000226755 | SCV002515757 | uncertain significance | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | no assertion criteria provided | research | ||
Nadeem Sheikh Lab, |
RCV002277588 | SCV002564649 | likely pathogenic | Acute myeloid leukemia | no assertion criteria provided | clinical testing |